ALK-Abelló — Investor Relations & Filings
ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2009 | 2009-02-23 | English | |
| Regulatory Filings 2009 | 2009-02-23 | Danish | |
| Annual Report 2009 | 2009-02-19 | Danish | |
| Annual Report 2009 | 2009-02-19 | English | |
| Major Shareholding Notification 2009 | 2009-02-06 | Danish | |
| Major Shareholding Notification 2009 | 2009-02-06 | English |
Browse filings by year
20 years- 2026 19 filings
- 2025 47 filings
- 2024 64 filings
- 2023 41 filings
- 2022 53 filings
- 2021 67 filings
- 2020 43 filings
- 2019 74 filings
- 2018 44 filings
- 2017 120 filings
- 2016 116 filings
- 2015 46 filings
- 2014 68 filings
- 2013 64 filings
- 2012 142 filings
- 2011 62 filings
- 2010 50 filings
- 2009 30 filings
- 2008 34 filings
- 2007 26 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2009
10 filings
| |||||
| 1713612 | Regulatory Filings 2009 | 2009-02-23 | English | ||
| 1713611 | Regulatory Filings 2009 | 2009-02-23 | Danish | ||
| 1713750 | Annual Report 2009 | 2009-02-19 | Danish | ||
| 1713748 | Annual Report 2009 | 2009-02-19 | English | ||
| 1714319 | Major Shareholding Notification 2009 | 2009-02-06 | Danish | ||
| 1714316 | Major Shareholding Notification 2009 | 2009-02-06 | English | ||
| 1714363 | Regulatory Filings 2009 | 2009-02-05 | Danish | ||
| 1714358 | Report Publication Announcement 2009 | 2009-02-05 | English | ||
| 1714916 | Regulatory Filings 2009 | 2009-01-22 | Danish | ||
| 1714913 | Capital/Financing Update 2009 | 2009-01-22 | English | ||
|
2008
5 filings
| |||||
| 1717448 | Regulatory Filings 2008 | 2008-11-21 | English | ||
| 1717447 | Regulatory Filings 2008 | 2008-11-21 | Danish | ||
| 1717460 | Remuneration Information 2008 | 2008-11-21 | English | ||
| 1717458 | Regulatory Filings 2008 | 2008-11-21 | Danish | ||
| 1717513 | Regulatory Filings 2008 | 2008-11-20 | Danish | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for ALK-Abelló, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ALK-Abelló via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/3351/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=3351 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=3351 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=3351 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 3351}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ALK-Abelló (id: 3351)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.